Real World Effectiveness of fixed combination of glargine 100 U/ml and lixisenatide therapy in outpatients with Type 2 Diabetes: A Retrospective Cohort Study SOLO

Background: The effectiveness and safety of a fixed combination of insulin glargine 100 ME/ml and lixisenatide for treatment of patients with type 2 diabetes (T2DM) has been demonstrated in randomized clinical trials, but there are still not enough data of it`s usage of it real clinical practice.Aim...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	M. B. Antsiferov, N. A. Demidov, M. A. Balberova, T. I. Safronova, O. A. Mishra, S. G. Magomedova
Format:	Artigo
Sprog:	Inglês
Udgivet:	Endocrinology Research Centre 2022-05-01
Serier:	Сахарный диабет
Fag:	fixed combination of insulin glargine 100 me/ml and lixisenatide type 2 diabetes glargine lixisenatide
Online adgang:	https://www.dia-endojournals.ru/jour/article/view/12809
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!